Percutaneous Puncture Surgery Robot Market Report 2025

The percutaneous puncture surgery robot market size has grown rapidly in recent years. It will grow from $1.76 billion in 2024 to $1.98 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth during the historic period was driven by the increasing prevalence of chronic diseases, rising healthcare expenditure and supportive government initiatives, a growing number of surgical procedures, expanding patient preference for non-invasive treatments, and wider adoption of automated instruments.

The percutaneous puncture surgery robot market size is expected to see rapid growth in the next few years. It will grow to $3.16 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth during the forecast period is fueled by rising demand for minimally invasive surgical procedures, growing reliance on robotic systems, increasing investments in healthcare automation, higher prevalence of neurological and musculoskeletal disorders, and increasing acceptance of robotic surgeries. The primary trends in the forecast period include advancements in artificial intelligence and machine learning, improvements in robotic-assisted surgery techniques, integration of robotics with imaging technologies, innovations in microrobots and surgical devices, and development of next-generation percutaneous puncture robots.

The growing preference for minimally invasive procedures is expected to drive the expansion of the percutaneous puncture surgery robot market. These procedures, which are performed through small incisions or openings, minimize patient trauma and shorten recovery times. The demand for such surgeries is rising because they offer quicker recovery, reduced complication risks, less pain, and smaller scars. This makes them an attractive option for patients looking for safer and faster treatments. Percutaneous puncture surgery robots enhance these procedures by offering precise needle guidance, making them particularly effective for tumor ablations and biopsies. By reducing surgical errors and providing real-time navigation, they improve both patient safety and procedural efficiency. For example, a report by the American Society of Plastic Surgeons in June 2024 revealed that minimally invasive procedures increased by 7% in 2023, outpacing traditional surgical methods by 2%. This trend is contributing to the growth of the percutaneous puncture surgery robot market.

Leading players in the percutaneous puncture surgery robot market are developing advanced technologies, such as vascular intervention surgical robots, to improve precision, reduce complications, and accelerate recovery. These robotic systems are specifically designed to assist in performing minimally invasive procedures on blood vessels, offering precise control when navigating catheters and guidewires. For instance, in December 2023, Robocath S.A.S., a French MedTech firm, collaborated with Microport Medical B.V. from China and received approval from the National Medical Products Administration (NMPA) for their R-ONE vascular intervention surgical robot. This robot aids interventional cardiologists in performing accurate, minimally invasive procedures, such as percutaneous coronary interventions (PCI), by enhancing control, improving safety, and minimizing radiation exposure. The robot features advanced dual-finger grasp mimic technology, enabling continuous rotation from 0 to 360 degrees and providing precise, hand-like manipulation for complex vascular lesions. Moreover, it reduces radiation exposure for both patients and operators through optimized robotic navigation and less reliance on fluoroscopy.

In February 2025, Toulouse University Hospital (CHU), located in France, acquired the Epione robotic platform from Quantum Surgical SAS to advance minimally invasive cancer treatments. This acquisition is part of the hospital's commitment to enhancing precision in cancer care and improving patient outcomes using state-of-the-art robotic technology. Quantum Surgical SAS, a French medical robotics company, specializes in percutaneous puncture surgery robots.

Major players in the percutaneous puncture surgery robot market are Intuitive Surgical Inc., Quantum Surgical SAS, iSYS Medizintechnik GmbH, Perfint Healthcare Private Limited, MicroPort MedBot (Group) Co. Ltd., Robocath S.A.S., XACT Robotics Inc., NDR Medical Technology, Yuanhua Technology Co. Ltd., BEC Medical Robotics, and Perlove Medical.

North America was the largest region in the percutaneous puncture surgery robot market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in percutaneous puncture surgery robot report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the percutaneous puncture surgery robot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A percutaneous puncture surgery robot is a medical robotic system designed to assist surgeons in performing minimally invasive procedures by precisely guiding needles or instruments through the skin to target internal tissues or organs. These robots enhance surgical accuracy, reduce human error, and minimize patient trauma compared to traditional manual puncture techniques.

The primary types of percutaneous puncture surgery robots include prostate puncture robots, lung puncture robots, kidney puncture robots, and pancreas puncture robots. A prostate puncture robot is a specialized system that helps surgeons accurately guide needles or instruments for minimally invasive procedures, such as biopsies or therapies, within the prostate gland. Based on surgical approach, these robots are classified into robot-assisted percutaneous surgery and traditional percutaneous surgery. They integrate advanced technologies such as robotic-assisted navigation, augmented reality, and artificial intelligence and machine learning. Applications span multiple surgical fields, including orthopedic, cardiovascular, neurological, urological, and general surgery, serving end-users such as hospitals, ambulatory surgical centers, and specialized clinics.

The percutaneous puncture surgery robot market research report is one of a series of new reports that provides percutaneous puncture surgery robot market statistics, including percutaneous puncture surgery robot industry global market size, regional shares, competitors with a percutaneous puncture surgery robot market share, detailed percutaneous puncture surgery robot market segments, market trends and opportunities, and any further data you may need to thrive in the percutaneous puncture surgery robot industry. This percutaneous puncture surgery robot market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The percutaneous puncture surgery robot market consists of revenues earned by entities by providing services such as surgical planning and simulation services, maintenance and technical support, remote surgery and teleoperation support, and research and development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The percutaneous puncture surgery robot market also includes sales of robotic arm systems, 3D imaging and navigation systems, needle insertion modules, endoscopic camera systems, computer-aided planning software, and haptic feedback systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.